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Characterization of a dysfunctional antithrombin variant 
“Antithrombin III Aalborg” 
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Introduction. An AT variant denoted AT-III Aalborg has been identified in patients suffering form 
venous thromboembolic disease. The variant is a type II AT deficiency with normal antigen and 
decreased activity levels, but only when measured with an anti-IIa method whereas anti-Xa activity is 
normal. The aim of this study was to elucidate and characterize AT-III Aalborg through a biophysical 
and proteomic approach. 
 
Method. To understand the cause of the dysfunction of this AT-variant several biophysical 
experiments and mass spectroscopic analyses were performed: 
 Identification of the disease-related modification by mass spectrometry (MS) and DNA-
diagnostics 
 Estimation of the rate constants for inhibition of thrombin and factor Xa 
 Estimation of the heparin binding affinity with Fluorescence spectroscopy 
 Investigation of the conformational stability of AT-III Aalborg by circular dichroism 
 Detection of Polymers by Dynamic light scattering. 
 Conformation and structural analysis by electrophoresis. 
 
Results. DNA-analysis and MS showed a serine to leucine conversion at position 394, i.e. in the 
reactive loop. MS did not indicate any other changes. The inhibition rate constant of AT-III Aalborg 
for IIa was 1/5
th
 of the normal whereas for Xa it was half of the normal. Heparin binding affinity was 
normal. Biophysical investigations did not indicate a changed conformational stability 
 
Conclusion. AT-III Aalborg has a change in the reactive loop which lowers the inhibition rate of IIa 
much more than expected. If the mutated AT had no effect at all, a rate constant of half the normal 
would be expected. This indicates that the mutated AT not only does not inactivate thrombin, but it 
inhibits the effect of the wt AT, further indicating that a type II AT deficiency may be more severe 
than a type I deficiency which may explain the severe phenotype of AT-III Aalborg. 
 
